Taysha Gene Therapies Inc (NASDAQ: TSHA) is -19.65% lower on its value in year-to-date trading and has touched a low of $1.19 and a high of $4.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TSHA stock was last observed hovering at around $1.93 in the last trading session, with the day’s loss setting it -0.54%.
Currently trading at $1.39, the stock is -19.49% and -15.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.46 million and changing -27.98% at the moment leaves the stock -32.17% off its SMA200. TSHA registered -56.15% loss for a year compared to 6-month loss of -33.81%. The firm has a 50-day simple moving average (SMA 50) of $1.6494 and a 200-day simple moving average (SMA200) of $2.049375.
The stock witnessed a -13.13% gain in the last 1 month and extending the period to 3 months gives it a -25.27%, and is -16.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.14% over the week and 9.04% over the month.
Taysha Gene Therapies Inc (TSHA) has around 73 employees, a market worth around $284.95M and $8.33M in sales. Profit margin for the company is -1071.62%. Distance from 52-week low is 16.81% and -67.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-67.04%).
The EPS is expected to shrink by -1.44% this year.
Taysha Gene Therapies Inc (TSHA) Top Institutional Holders
167.0 institutions hold shares in Taysha Gene Therapies Inc (TSHA), with institutional investors hold 100.66% of the company’s shares. The shares outstanding are 204.94M, and float is at 165.01M with Short Float at 15.30%. Institutions hold 82.20% of the Float.
The top institutional shareholder in the company is FMR LLC with over 21.21 million shares valued at $47.51 million. The investor’s holdings represent 9.1103% of the TSHA Shares outstanding. As of 2024-06-30, the second largest holder is RTW INVESTMENTS, LP with 18.8 million shares valued at $42.11 million to account for 8.075 of the shares outstanding. The other top investors are AVORO CAPITAL ADVISORS LLC which holds 18.65 million shares representing 8.0104% and valued at over $41.78 million, while BLACKROCK INC. holds 5.0435 of the shares totaling 11.74 million with a market value of $26.3 million.
Taysha Gene Therapies Inc (TSHA) Insider Activity
The most recent transaction is an insider purchase by Manning Paul B, the company’s 10% Owner. SEC filings show that Manning Paul B bought 1,333,333 shares of the company’s common stock on Jun 27 ’24 at a price of $2.25 per share for a total of $3.0 million. Following the purchase, the insider now owns 1.33 million shares.
